Patents Represented by Attorney Monique Morneault
  • Patent number: 5846561
    Abstract: Recognizing substances, including epidermal growth factor, gelatin, collagen and hyaluronic acid, have been covalently bound to liposomal surfaces and utilized to attach liposomes onto a cellular or an extracellular matrix (ECM) target site. These "bioadhesive" liposomes offer several advantages including the mutual protection of both the drug and biological environment; an increase in drug bioavailability and retention at the target site; and improved adherence or adhesion to the designated target site.
    Type: Grant
    Filed: December 10, 1996
    Date of Patent: December 8, 1998
    Assignee: Baxter International Inc.
    Inventor: Rimona Margalit
  • Patent number: 5650421
    Abstract: A pharmaceutical composition comprising a solution having an effective amount of famotidine, the solution having a pH in the range of about 4.5 to about 8.0, and a shelf life greater than 30 days.
    Type: Grant
    Filed: March 31, 1995
    Date of Patent: July 22, 1997
    Assignee: Baxter International Inc.
    Inventors: Allan E. Titus, Douglas G. Johnson
  • Patent number: 5603872
    Abstract: Recognizing substances, including epidermal growth factor, gelatin, collagen and hyaluronic acid, have been covalently bound to liposomal surfaces and utilized to attach liposomes onto a cellular or an extracellular matrix (ECM) target site. These "bioadhesive" liposomes offer several advantages including the mutual protection of both the drug and biological environment; an increase in drug bioavailability and retention at the target site; and improved adherence or adhesion to the designated target site.
    Type: Grant
    Filed: October 3, 1994
    Date of Patent: February 18, 1997
    Assignee: Baxter International Inc.
    Inventor: Rimona Margalit